1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: IM-T-hLL1-02, NCT00603668
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 to 79 Sponsor: Pharmaceutical / Industry Protocol IDs: KMC-07-0080-CTIL, NCT00868478
|
|
3.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OSU-09024, NCI-2011-03150, NCT00989586
|
|
4.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0608008669, NCT00504972
|
|
5.
|
Phase: Phase I Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: IM-T-IMMU-115-03, NCT01663766
|